下载 APKPure App
可在安卓获取POINT 1 Study的历史版本
点1研究的工具，登记病人管理参与研究。
"Please Note: This app is only for use by those participating in this study. The POINT 1 Study is a two part pediatric
study of Afrezza inhaled human insulin in pediatric patients with type 1 diabetes mellitus.
The POINT 1 Study App is a tool for for enrolled patients to manage and understand study participation."
最新版本0.3.26更新日志
Last updated on 2018年07月23日
1. Removed bluetooth option for Glucometer reading transfer
2. Added logic into the app where if a Glucose reading of less than 70mg/dl (Hypoglycemic Event), it automatically redirects you to symptom reporting screens.
翻译中...
POINT 1 Study
0.3.26 by Parallel 6, Inc.
2018年07月23日